Alcohol, Other Drugs, and Health: Current Evidence

Search
Menu Search
  • Home
  • Current Issue
  • Issues
  • Free Subscriptions
  • Podcast
  • Slide Presentations
  • Ethical Conduct of AOD Research
  • Curricula and Links
  • About the Newsletter
  • Contact Us
Search

September-October 2021

Interventions and Assessments

  • Does Extended Release Buprenorphine Improve Treatment Retention Compared with Other Medications for Opioid Use Disorder?
  • Availability of Medications for Opioid Use Disorder Remains Strikingly Low in Specialty Addiction Treatment Programs

Health Outcomes

  • High-dose Benzodiazepines Associated With Non-fatal Drug Poisonings in Patients Receiving Buprenorphine
  • Many Pharmacies in US Counties With High Opioid Overdose Rates Do Not Provide Buprenorphine
  • Escalating Alcohol Use During Adolescence Is Associated With Non-medical Opioid Use in Young Adulthood
  • Is Cannabis Legalization Associated with an Increase in Cannabis-related Motor Vehicle Crash Fatalities?

HIV and HCV

  • Patients Receiving Methadone More Likely to Undergo Hepatitis C Screening Among Medicaid-insured New Yorkers With Opioid Use Disorder

Prescription Drugs and Pain

  • Urine Drug Testing Among People Prescribed Opioid Medications for Chronic Pain: Useful Tool or Blunt Instrument?

Download PDF of newsletter

Slide Presentations

  • Journal Club Sept-Oct 2021
  • Update Sept-Oct 2021
Grayken Center for Addiction at Boston Medical Center

Bringing you the latest clinically relevant research on substance use and health.

Boston University
Boston University Medical Center
Grayken Center for Addiction